Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Originally published as JCO Early Release 10.1200/JCO.2008.18.9035 on December 29 2008

Journal of Clinical Oncology, Vol 27, No 5 (February 10), 2009: pp. 733-739
© 2009 American Society of Clinical Oncology.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blumenthal, D. T.
Right arrow Articles by Corn, B. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blumenthal, D. T.
Right arrow Articles by Corn, B. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Neurooncology

Short Delay in Initiation of Radiotherapy May Not Affect Outcome of Patients With Glioblastoma: A Secondary Analysis From the Radiation Therapy Oncology Group Database

Deborah T. Blumenthal, Minhee Won, Minesh P. Mehta, Walter J. Curran, Luis Souhami, Jeff M. Michalski, C. Leland Rogers, Benjamin W. Corn

From the Departments of Oncology, Neuro-Oncology Service, and Radiation Oncology at Tel Aviv Medical Center, Tel Aviv, Israel; Statistical Unit of the Radiation Therapy Oncology Group; Department of Radiation Oncology, Thomas Jefferson University Hospital; Philadelphia, PA; Department of Radiation Oncology, University of Wisconsin, Madison, WI; Mayo Clinic, Rochester, MN; Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA; Department of Radiation Oncology, Gamma West Radiation Therapy, Salt Lake City, UT; and Department of Radiation Oncology, McGill University, Montreal, Quebec, Canada.

Corresponding author: Deborah T. Blumenthal, MD, Department of Oncology, Tel Aviv Sourasky Medical Center, 6 Weizman St, Tel-Aviv, Israel; e-mail: deborahblumenthal{at}gmail.com.

Purpose To analyze the Radiation Therapy Oncology Group (RTOG) database of patients with glioblastoma and appraise whether outcome was influenced by time to initiation of radiation therapy (RT).

Patients and Methods From 1974 through 2003, adult patients with histologically confirmed supratentorial glioblastoma were enrolled onto 16 RTOG studies. Of 3,052 enrolled patients, 197 patients (6%) were either initially rendered ineligible or had insufficient chronologic data, leaving a cohort of 2,855 patients for the present analysis. We selected four patient groups based on the interval from surgery to the start of RT: ≤ 2 weeks, 2 to 3 weeks, 3 to 4 weeks, more than 4 weeks to the protocol eligibility limit of 6 weeks. Survival times were estimated by the Kaplan-Meier method. Multivariate analysis incorporated variables of time interval, recursive partitioning analysis (RPA) class, and treatment regimen.

Results No decrement in survival could be identified with increasing time to initiation of RT. Among our four temporal groupings, median survival time was unexpectedly and significantly greater in the group with the longest interval (> 4 weeks) than in those with the shortest delay (≤ 2 weeks): respectively, 12.5 months versus 9.2 months (P < .0001). On multivariate analysis, with overall survival as the end point, time interval more than 4 weeks and lower RPA class were both significant predictors of improved outcome. Treatment regimen was not a significant factor.

Conclusion There is no evident reduction in survival by delaying initiation of RT within the relatively narrow constraint of 6 weeks. An unanticipated yet significantly superior outcome was identified for patients for whom RT was delayed beyond 4 weeks from surgery.

Supported by Radiation Therapy Oncology Group (D.T.B.).

Presented at the 11th Annual Meeting of the Society of Neuro-Oncology, November 15-19, 2006, Orlando, FL.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online